<DOC>
	<DOCNO>NCT00141141</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Atorvastin v Simvastatin decrease LDL-C diabetic subject hypercholesterolemia end treatment phase .</brief_summary>
	<brief_title>Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Diagnosis type 2 diabetes mellitus LDLC &gt; 130 mg/dL Insulin therapy Clinically relevant organ disease ( creatininemia &gt; 2mg/dL , CHF NYHA III IV )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>